Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 5:01 PM ET

Date/Time Source News Release
05/29/2025 04:01 PM EDT Business Wire Arcturus Therapeutics to Attend Upcoming Investor Conferences
05/12/2025 04:01 PM EDT Business Wire Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress
04/22/2025 04:01 PM EDT Business Wire Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
04/10/2025 08:00 AM EDT Business Wire Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
03/28/2023 04:01 PM EDT Business Wire Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress
11/01/2022 06:05 PM EDT Business Wire Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
11/01/2022 06:00 PM EDT PR Newswire CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology
10/26/2022 04:30 PM EDT Business Wire Arcturus Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 9, 2022
09/27/2022 06:00 PM EDT Business Wire Arcturus Therapeutics to Attend the Following Investor Conferences
09/01/2022 04:00 PM EDT Business Wire Arcturus Therapeutics to Attend the Following Investor Conferences
Page

Additional News

As of June 4, 2025 • 5:01 PM ET

Date/Time Source News Release
06/03/2025 09:55 AM EDT Zacks Wall Street Analysts Think Arcturus Therapeutics (ARCT) Could Surge 371.35%: Read This Before Placing a Bet
05/18/2025 03:52 AM EDT Stock Traders Daily Trend Tracker for (ARCT)
05/15/2025 09:55 AM EDT Zacks Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade
05/12/2025 07:41 PM EDT SeekingAlpha Arcturus signals extended cash runway into 2028 with strategic shift toward CF and OTC mRNA therapeutics
05/12/2025 07:40 PM EDT SeekingAlpha Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2025 Earnings Call Transcript
05/12/2025 05:10 PM EDT Zacks Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates
05/12/2025 04:03 PM EDT SeekingAlpha Arcturus Therapeutics GAAP EPS of -$0.52 beats by $0.66, revenue of $29.38M beats by $6.03M
05/12/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - Arcturus Therapeutics Holdings Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.